Biotechnology - Health Technology Insights

Genentech Gazyva Shows Strong Results in Lupus Phase III Trial

Genentech Gazyva Shows Strong Results in Lupus Phase III Trial

November 3, 2025

Moonlight Therapeutics Gets FDA Clearance for MOON101 Trial

October 17, 2025

BridGene Raises $28 Million to Boost BGC-515 Development

October 16, 2025

Tubulis Raises €308 Million Series C to Boost ADC Development

October 15, 2025

Next Health Forms Scientific Advisory Council for Longevity

October 15, 2025

MilliporeSigma to Acquire JSR’s Chromatography Business

October 15, 2025

WellTheory Raises $14Million to Build the Category Leader in Autoimmune Care

October 14, 2025

First Patient Treated With Leqembi (lecanemab) in the Nordics

October 14, 2025

Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities

October 14, 2025

Asia University Partners with NucleicAI for AI Life Science Data

October 14, 2025

Creyos Launches Care Planning for Dementia Support

October 14, 2025

Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156

October 2, 2025

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 11 November 2025

Health Technology Insights: Latest News And Innovations – Roundup 9 December 2025

AI-Adoption-in-Healthtech-Is-Accelerating-Top-Trends-Every-Leader-Should...

AI Adoption in Healthtech: Top Trends Every Leader Should Know

Novartis ianalumab Shows Strong Disease Control in Patients With Immune Thrombocytopenia

Novartis ianalumab Shows Strong Disease Control in Patients With Immune Thrombocytopenia

Teva Pharmaceuticals Files NDA for Monthly Olanzapine Schizophrenia Treatment

Teva Pharmaceuticals Files NDA for Monthly Olanzapine Schizophrenia Treatment

Aprea Therapeutics Announces $3.1Million At-Market Financing

Aprea Therapeutics Announces $3.1Million At-Market Financing

Findhelp and AIDA Healthcare Partner to Improve Post-Acute Care Referrals

Findhelp and AIDA Healthcare Partner to Improve Post-Acute Care Referrals